Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues

Clinical Chemistry

Volumn 47, Issue 2, 2001, Pages 237-246

  Lou, L Y ^a   Grass, L ^a   Howarth, D J C ^a   Thibault, P ^a   Ong, H ^a   Diamandis, E P ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; KALLIKREIN 10; KALLIKREIN 2; KALLIKREIN 6; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

AMNION FLUID; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ASSAY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; PICHIA PASTORIS; SEMINAL PLASMA; SERUM; TISSUE DISTRIBUTION;

ORYCTOLAGUS CUNICULUS; PICHIA PASTORIS;

EID: 0035134145     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.2.237     Document Type: Article

References (21)

1. Bioregulation of kinins: Kallikreins, kininogens, and kininases
2. The molecular biology of the kallikreins and their roles in inflammation
3. Characterization of the human kallikrein locus
4. Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era
5. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): Two closely related, but distinct, kallikreins in the prostate
6. The new human kallikrein gene family: Implications in carcinogenesis
7. New nomenclature for the human tissue kallikrein gene family
8. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression
9. Structural characterization and mapping of the normal epithelial cell-specific 1 gene
10. The role for NES1 serine protease as a novel tumor suppressor
11. Down-regulation of the normal epithelial cell-specific 1 (NES1) gene is associated with unfavorable outcome in prostate cancer
12. Rapid 'de novo' peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/time-of-light mass spectrometer
13. Enzymatically amplified timeresolved fluorescence immunoassay with terbium chelates
14. Ultrasensitive time-resolved immunofluorometric assay of prostate specific antigen in serum and preliminary clinical studies
15. Proposal for a common nomenclature for sequence ions in mass spectra of peptides
16. 1antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
17. 1-antichymotrypsin
18. 2macroglobulin
19. Multiple forms of prostate-specific antigen in serum: Differences in immunorecognition by monoclonal and polyclonal assays
20. Ultrasensitive detection of prostate specific antigen by a time-resolved immunofluorometric assay and the Immulite® Immunochemiluminescent third generation assay: Potential applications in prostate and breast cancers